HedgeChatter

  • Home /
  • Tag Archives

intercept

Pipeline Updates Make These Three Biotech Stocks … – Benzinga

Related ICPTCNBC’s Meg Tirrel Speculates About Gilead’s New AcquisitonHow Wedbush’s Liana Moussatos Is Trading These Biopharma StocksShaken, Not Stirred: Is The ‘Biotech Bubble’ Beginning To Burst?(Seeking Alpha)Related Sarepta Therapeutics Announces New England Journal of Medicine Publication of Phase I Clinical Data of Marburg Drug Candidate, AVI-7288, Supporting Safety of the PMOplus® platformShort-Sellers Betting Against These BiotechsSarepta Posts Narrower-than-Expected Loss in […]

August 10, 2015 ByTipRanks , , , , , , , , , Comments Off on Pipeline Updates Make These Three Biotech Stocks … – Benzinga read more

4 Biotech and Pharma Stocks Projected to Rise 50 … – 24/7 Wall St.

Biotech has been one hot sector again in 2015. Two key biotech exchange traded funds are up 20% or so on average year-to-date. 247 Wall St. could not help but notice four analyst calls this past week in which upside of 50% to 100% was predicted for four biotech and specialty pharma stocks.Before just chasing these higher, investors should understand […]

April 18, 2015 ByJon C. Ogg , , , , , , , Comments Off on 4 Biotech and Pharma Stocks Projected to Rise 50 … – 24/7 Wall St. read more

CAPScall of the Week: Intercept Pharmaceuticals

For years, satirical late-night TV host Stephen Colbert has been running a series on his show called “Better Know a District,” which highlights one of the 435 U.S. congressional districts and its representative. While I am no Stephen Colbert, I ;am ;brutally inquisitive when it comes to the 5,000-plus listed companies on the U.S. stock exchanges.That’s why I’ve made it […]

April 6, 2015 ByMaryii , , , , , , , , , , , Comments Off on CAPScall of the Week: Intercept Pharmaceuticals read more

Is The Biotech Stock Correction A Buying Opportunity Or A Wake Up Call?

Disclosure: I own shares of AMGN and GILDBiotechnology stocks have been in a sharp correction this week. The iShares Nasdaq Biotechnology ETF dropped close to one-percent in early Thursday trade, following a 1.89% decline on Wednesday; and the SPDR S&P biotech ETF registered similar losses.Is the correction a buying opportunity or a wake up call?Both.On the one side, the correction […]

March 26, 2015 ByPanos Mourdoukoutas , , , , , , , Comments Off on Is The Biotech Stock Correction A Buying Opportunity Or A Wake Up Call? read more

Is Intercept The Next Biotech To Break Out?

View gallery.Biotech stocks have been breaking to new highs all over the market. Here are just a few:Esperion Therapeutics broke to a new high last week and skyrocketed Tuesday.
Ampio Pharmaceuticals bolted higher last week and touched a new high Wednesday.
Jazz Pharmaceuticals just hit a new high Wednesday as well.
The list goes on and on. Whether it is Receptos, NewLink Genetics, Biogen […]

March 18, 2015 , , , , , , , , , , , Comments Off on Is Intercept The Next Biotech To Break Out? read more

3 Biotech Stocks to Buy in March

“Our life is March weather, savage and serene in one hour.” — Ralph Waldo Emerson

Substitute “biotechs” for “our life” and you have the investing version of Emerson’s quote. Depending on how binary events go, they can certainly become savage or serene quite quickly.We asked our team of experts for their top biotech picks to watch this month. Read below to […]

March 11, 2015 , , , , , , , , Comments Off on 3 Biotech Stocks to Buy in March read more

Biotech stocks to watch ahead of liver disease conference

The number of patients with this chronic liver disease, which can lead to permanent liver scarring, eclipses that of hepatitis C in the U.S., RBC’s Yee said. While a significant number aren’t diagnosed, “we believe, based on survey work, that there are hundreds of thousands of patients with diagnosed NASH,” and that the global market for NASH drugs may reach […]

November 7, 2014 Byunknown , , , , , , , , , , , Comments Off on Biotech stocks to watch ahead of liver disease conference read more